Page 3 - ESHRE2019
P. 3
CONTENTS
Course coordination, course type, course description, target audience,
educational needs and expected outcomes 03
Programme 05 Speakers’ contributions
Notes
110
Pre-IVF treatment of endometriosis: What, when and for how long? 07
Johnny Awwad, Lebanon
Pre-IVF treatment of uterine fibroids: When does intervention become beneficial? 23
Mohamed Aboulghar, Egypt
Pre-IVF treatment of uterine adenomyosis: Is intervention useful at all? 44
Togas Tulandi, Canada
Treatment of severe tubal disease prior to IVF: To treat or not to treat? 53
John Petrozza, U.S.A.
Pre-IVF treatment of uterine cavity defects: The do’s and the don’ts 61
Togas Tulandi, Canada
Pre-IVF thyroid function screening –why test, what to test and how to interpret 71
Lubna Pal, U.S.A.
Pre-IVF management of PCOS: How significant is the role of insulin sensitizers? 86
Lubna Pal, U.S.A.
Pre-IVF management of poor responder: Much ado about nothing? 98
John Petrozza, U.S.A.
PRECONGRESS COURSE 16 I VIENNA, AUSTRIA – 23 JUNE 2019 01
